Search research articles
Contact Us
Filters
Showing results (551-560 of 605) with videos related to
Page
of 61
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 14, 2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy
Geoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, et al.
The Canadian Journal of Cardiology
|
May 11, 2021
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials
Guglielmo Gallone, Luca Baldetti, Filippo Angelini, et al.
Circulation
|
November 16, 2017
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2
James G Jollis, Hussein R Al-Khalidi, Mayme L Roettig, et al.
Circulation Research
|
December 7, 2017
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis
Jay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Lancet (London, England)
|
September 6, 2013
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
Roxana Mehran, Usman Baber, Philippe Gabriel Steg, et al.
Circulation. Cardiovascular Interventions
|
March 29, 2020
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry
Sabato Sorrentino, Samantha Sartori, Usman Baber, et al.
The American Journal of Cardiology
|
July 30, 2017
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study)
Björn Redfors, Ori Ben-Yehuda, Sheng-Hsuan Lin, et al.
International Journal of Cardiology
|
September 5, 2017
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Gennaro Giustino, Björn Redfors, Roxana Mehran, et al.
American Heart Journal
|
June 7, 2011
A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)
Emerson C Perin, Guilherme V Silva, Timothy D Henry, et al.
JACC. Cardiovascular Interventions
|
May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry
Lauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
Page
of 61
Search research articles
Search
Showing results (551-560 of 605) with videos related to
Sort By:
Page
of 61
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 14, 2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy
Geoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, et al.
The Canadian Journal of Cardiology
|
May 11, 2021
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials
Guglielmo Gallone, Luca Baldetti, Filippo Angelini, et al.
Circulation
|
November 16, 2017
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2
James G Jollis, Hussein R Al-Khalidi, Mayme L Roettig, et al.
Circulation Research
|
December 7, 2017
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis
Jay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Lancet (London, England)
|
September 6, 2013
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
Roxana Mehran, Usman Baber, Philippe Gabriel Steg, et al.
Circulation. Cardiovascular Interventions
|
March 29, 2020
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry
Sabato Sorrentino, Samantha Sartori, Usman Baber, et al.
The American Journal of Cardiology
|
July 30, 2017
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study)
Björn Redfors, Ori Ben-Yehuda, Sheng-Hsuan Lin, et al.
International Journal of Cardiology
|
September 5, 2017
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Gennaro Giustino, Björn Redfors, Roxana Mehran, et al.
American Heart Journal
|
June 7, 2011
A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)
Emerson C Perin, Guilherme V Silva, Timothy D Henry, et al.
JACC. Cardiovascular Interventions
|
May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry
Lauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
Page
of 61